SKF-39315

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

SKF-39315
File:SKF-39315.svg
Clinical data
Other namesSKF39315; SKF-39315A; SK&F-39315A
Identifiers
  • 2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
CAS Number
PubChem CID
ChemSpider
ChEMBL
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H13NO2
Molar mass179.219 g·mol−1
3D model (JSmol)
  • C1CNCCC2=CC(=C(C=C21)O)O
  • InChI=1S/C10H13NO2/c12-9-5-7-1-3-11-4-2-8(7)6-10(9)13/h5-6,11-13H,1-4H2
  • Key:LPJMTSQTVDKBCO-UHFFFAOYSA-N

SKF-39315 is a monoamine receptor modulator of the 3-benzazepine family.[1] It is a cyclized phenethylamine analogue of the neurotransmitter dopamine.[1] The drug shows affinities (Ki) of 12 nM for the dopamine D2 receptor and 5,200 nM for the dopamine D1 receptor.[1] It also has direct and indirect adrenergic actions.[1] The 1-phenyl derivative of SKF-39315 is SKF-38393, which has reversed activities at dopamine receptors compared to SKF-39315 and acts as a selective dopamine D1-like receptor agonist.[1] SKF-39315 was first described in the scientific literature by at least 1988.[1]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ a b c d e f Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
[edit | edit source]